2009 Annual Report: Shandong Pharmaceutical Glass

Date: 25 March 2010
Source: Tradingmarkets.com
The following is a table showing the main business indicators for 2009 of Shanghai-listed Shandong Pharmaceutical Glass Co.

Ltd. (600529.SH): 2009/adjusted 2008/adjusted Earnings per share (yuan) 0.56/0.57 0.53/0.47 Net assets per share (yuan) 6.18 5.65 Return on net assets (pct) 9.5 9.77 Net cash flow (yuan) 0.97 0.36 Main operating turnover (million yuan) 1242.1585 1158.2921 Net profit attributable to group (million yuan) 144.3619(147.8822) 135.1625 Distribution plan 0.1 yuan cash dividend per share (Tax included)
 
Read more here.

600450 2009 Annual Report: Shandong Pharmaceutical Glass glassonweb.com

See more news about:

Others also read

LandGlass Won the Silver Award at “The Third China Dual-use Technological Innovation Application Contest”.
The 2019 exhibition will be held in Guangzhou-Pazhou-Canton Fair from August 22nd to 24th.
Recently, LandGlass was named as one of the “Outstanding Private Enterprises in Luoyang - High Growth Innovative Entities” by the CPC Luoyang Municipal Committee and the People’s Government of Luoyang Municipality.
On November 22, the municipal office of civilization and office of credibility held the “2018 Credible Private Enterprises” commendation conference at the 2nd floor conference room of the Luoyang city hall.
Permasteelisa S.p.A welcomes the LIXIL Group Corporation’s announcement about the agreement with Grandland Holdings Group Limited, a leading Chinese architectural design and construction company, to terminate planned Permasteelisa transaction.
Asia’s No. 1 fenestration exhibition - FENESTRATION BAU China 2018 (”FBC”) concluded on November 3, 2018 in Beijing.

From industry

No. 160 Yichuan Rd.,
Jiaonan Shi
Qingdao Shi
Shandong Sheng, 266000
China

Add new comment